диссертации / 129
.pdf141
93)Khan, O. Chronic cerebrospinal venous insufficiency and multiple sclerosis / O.Khan, M.Filippi, M.S.Freedman et al. // Ann. Neurol. – 2010. – V. 67(3). – P. 286–290.
94)Kivisakk, P. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin / P.Kivisakk, D.J.Mahad, M.K.Callahan, C.Trebst, B.Tucky et al. // Proc. Natl. Acad. Sci. USA. – 2003. – V. 100(14). – P. 8389–8394.
95)Kniesel, U. Development of blood-brain barrier tight junctions in the rat cortex / U.Kniesel, W.Risau, H.Wolburg // Brain. Res. Dev. Brain. Res. –
1996. – V. 96(1-2). – P. 229–240.
96)Kohriyama, T. Endothelial cell activation and/or injury in multiple sclerosis: analysis with von Willebrand factor and thrombomodulin / T.Kohriyama, H.Maruyama, K.Kurokawa, T.Harada, S.Nakamura // Rinsho Shinkeigaku. – 1997. – V. 37(4). – P. 287-291.
97)Kuenz, B. Plasma levels of soluble adhesion molecules sPECAM-1, sPselectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis / B.Kuenz, A.Lutterotti, M.Khalil, R.Ehling, C.Gneiss et al. // J. Neuroimmunol. – 2005. – V. 167(1-2). – P. 143-149.
98)Lannes-Vieira, J. The inflammatory lesion of T cell line transferred experimental autoimmune encephalomyelitis of the Lewis rat: distinct nature of parenchymal and perivascular infiltrates / J.Lannes-Vieira, J.Gehrmann, G.W.Kreutzberg, H.Wekerle // Acta. Neuropathol. – 1994. – V. 87(5). – P. 435-442.
99)Lassmann, H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions / H.Lassmann // J. Neurol. Sci. – 2003. – V. 206(2). – P. 187–
191.
142
100) Law, M. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter / M.Law, A.M.Saindane, Y.Ge, J.S.Babb, G.Johnson et al. // Radiology. – 2004.
– V. 231(3). – P. 645-652.
101)Lawrence, M.B. Leukocytes roll on a selectin at physiological flow rates: distinction from and prerequisite for adhesion through integrins / M.B.Lawrence, T.A.Springer // Cell. – 1991. – V. 65(5). – P. 859–874.
102)Ledue, T.B. Analytical evaluation of particle–enhanced immunonephelometric assays for C–reactive protein, serum amyloid A, and mannose–binding protein in human serum / T.B.Ledue, D.L.Weiner, J.D.Sipe, S.E.Poulin, M.F.Collins et al. // Ann. Clin. Biochem. – 1998. – V. 35 (Pt.6). – P. 745-753.
103)Lee, B.P.L. Lymphocyte transmigration in the brain: a new way of thinking / B.P.L.Lee, B.A.Imhof // Nat. Immunol. – 2008. – V. 9(2). – P. 117118.
104)Ley, K. Molecular mechanisms of leukocyte recruitment in the inflammatory process / K.Ley // Cardiovasc. Res. – 1996. – V. 32(4). – P. 733–
742.
105)Ley, K. Getting to the site of inflammation: the leukocyte adhesion cascade updated / K.Ley, C.Laudanna, M.I.Cybulsky, S.Nourshargh // Nat. Rev. Immunol. – 2007. – V. 7(9). – P. 678–689.
106)Libby, P. Inflammation in atherosclerosis / P.Libby // Arterioscler. Thromb. Vasc. Biol. – 2012. – V. 32(9). – P. 2045-2051.
107)Losy, J. Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions / J.Losy, A.Niezgoda, M.Wender // J. Neuroimmunol. – 1999. – V. 99(2). – P. 169-172.
143
108)Lowery-Nordberg, M. The effects of high dose interferon-β1a on
plasma microparticles: Correlation with MRI parameters / M.LoweryNordberg, E.Eaton, E.Gonzalez-Toledo, M.K.Harris, K.Chalamidas et al. // J. Neuroinflammation. – 2011. – V. 8. – P. 43.
109)Lusher, T.F. Biology of the endothelium / T.F.Lusher, M.Barton // Clin. Cardiology. – 1997. – V. 20(11 Suppl.2). – P. 3-10.
110)Lyck, R. T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells / R.Lyck, Y.Reiss, N.Gerwin, J.Greenwood, P.Adamson et al. // Blood. – 2003. – V. 102(10). – P. 36753683.
111)López-Pedrera, C. Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions / C.López-Pedrera,
C.Pérez-Sánchez, M.Ramos-Casals, M.Santos-Gonzalez, A.Rodriguez-Ariza et
al. // Clin. Dev. Immunol. – 2012. – V. 2012. – P. 974648.
112)Mancini, M. Multiple sclerosis: cerebral circulation time / M.Mancini, V.B.Morra, O.Di Donato, V.Maglio, R.Lanzillo et al. // Radiology. – 2012. – V. 262(3). – P. 947-955.
113)Mancini, M. Internal jugular vein blood flow in multiple sclerosis
patients and matched controls / M.Mancini, R.Lanzillo, R.Liuzzi, O.Di Donato, M.Ragucci et al. // PLoS One. – 2014. – V. 9(3). – P. e92730.
114) Manouchehrinia, A. Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study / A.Manouchehrinia, C.R.Tench, J.Maxted, R.H.Bibani, J.Britton et al. // Brain. – 2013. – V. 136(Pt. 7). – P. 2298–2304.
144
115)Matsumura, T. Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin / T.Matsumura, K.Wolff, P.Petzelbauer // J. Immunol. –1997. – V. 158(7). – P. 3408–3416.
116)Mayer, C.A. The perfect crime? CCSVI not leaving a trace in MS / C.A.Mayer, W.Pfeilschifter, M.W.Lorenz, M.Nedelmann, I.Bechmann et al. // J. Neurol. Neurosurg. Psychiatry. – 2011. – V. 82(4). – P. 436–440.
117)McCandless, E.E. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis / E.E.McCandless, L.Piccio, B.M.Woerner, R.E.Schmidt, J.B.Rubin et al. // Am. J. Pathol. – 2008.
– V. 172(3). – P. 799–808.
118)McCandless, E.E. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis / E.E.McCandless, Q.Wang, B.M.Woerner, J.M.Harper, R.S.Klein // J. Immunol. – 2006. – V. 177(11). – P. 8053–8064.
119)McDonnell, G.V. Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease / G.V.McDonnell, S.A.McMillan, J.P.Douglas, A.G.Droogan, S.A.Hawkins // J. Neurol. – 1999. – V. 246(2). – P. 87-92.
120)Minagar, A. Blood-brain barrier disruption in multiple sclerosis / A.Minagar, J.S.Alexander // Mult. Scler. – 2003. – V. 9(6). – P. 540-549.
121)Minagar, A. Elevated plasma endothelial microparticles in multiple sclerosis / A.Minagar, W.Jy, J.J.Jimenez, W.A.Sheremata, L.M.Mauro et al. // Neurology. – 2001. – V. 56(10). – P. 1319-1324.
122)Minagar, A. Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells / A.Minagar, D.Ostanin, A.C.Long, M.Jennings, R.E.Kelley et al. // Mult. Scler. – 2003. – V. 9(3). – P. 235–238.
145
123)Mitrovic, B. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes / B.Mitrovic, L.J.Ignarro, H.V.Vinters, M.A.Akers, I.Schmid et al. // Neuroscience. – 1995. – V. 65(2). – P. 531–539.
124)Moncada, S. Nitric oxide: physiology, pathophysiology and pharmacology / S.Moncada, R.M.J.Palmer, E.A. Higgs // Pharmacol. Rev. –
1991. – V. 43. – P. 109-142.
125)Muller, W.A. A human endothelial cell-restricted, externally disposed plasmolemmal protein enriched in intercellular junctions / W.A.Muller, C.M.Ratti, S.L.McDonnell, Z.A.Cohn // J. Exp. Med. – 1989. – V. 170(2). – P. 399–414.
126)Nakagomi, A. Interferon–y and lipopolysaccharide potentiate monocyte tissue factor induction by C–reactive protein. Relationship with age, sex, and hormone replacement treatment / A.Nakagomi, S.B.Freedman, C.L.Geczj // Circulation. – 2000. – V. 101. – P. 1785–1791.
127)Napoli, I. Protective effects of microglia in multiple sclerosis / I.Napoli, H.Neumann // Exp. Neurol. – 2010. – V. 225(1). – P. 24–28.
128)Niezgoda, A. Pecam-1 expression in patients with relapsing-remitting multiple sclerosis / A.Niezgoda, J.Losy // Folia. Morphol. (Warsz). – 2002. – V. 61(3). – P. 143-145.
129)Noubade, R. Von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis / R.Noubade, R.del Rio, B.McElvany, J.F.Zachary, J.M.Millward et al. // Am. J. Pathol. – 2008. – V. 173(3). – P. 892-900.
130)O’Gorman, C. Environmental Risk Factors for Multiple Sclerosis: A Review with a Focus on Molecular Mechanisms / C.O’Gorman, R.Lucas,
B.Taylor // Int. J. Mol. Sci. – 2012. – V. 13(9). – P. 11718–11752.
146
131)Peschen, M. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency / M.Peschen, T.Lahaye, B.Hennig, A.Weyl, J.C.Simon et al. // Acta. Derm. Venereol. – 1999. – V. 79(1). – P. 27-32.
132)Podgrabinska, S. Molecular characterization of lymphatic endothelial cells / S.Podgrabinska, P.Braun, P.Velasco, B.Kloos, M.S.Pepper et al. // Proc. Natl. Acad. Sci. USA. – 2002. – V. 99(25). – P. 16069–16074.
133)Qiu, J. Venous abnormalities and multiple sclerosis: another breakthrough claim? / J.Qiu // Lancet. Neurol. – 2010. – V. 9(5). – P. 464–465.
134)Qiu, W. Wedge-shaped medullary lesions in multiple sclerosis / W.Qiu, S.Raven, J.S.Wu, W.M.Carroll, F.L.Mastaglia et al. // J. Neurol. Sci. – 2010. – V. 290(1-2). – P. 190–193.
135)Raine, C.S. Homing to central nervous system vasculature by antigenspecific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination / C.S.Raine, B.Cannella, A.M.Duijvestijn, A.H.Cross // Lab. Invest. – 1990. – V. 63(4). – P. 476–489.
136)Ranadive, S.M. Vascular dysfunction and physical activity in multiple sclerosis / S.M.Ranadive, H.Yan, M.Weikert, A.D.Lane, M.A.Linden et al. // Med. Sci. Sports. Exerc. – 2012. – V. 44(2). – P. 238-243.
137)Ransohoff, R.M. Three or more routes for leukocyte migration into the central nervous system / R.M.Ransohoff, P.Kivisakk, G.Kidd // Nat. Rev. Immunol. – 2003. – V. 3(7). – P. 569–581.
138)Rashid, W. Abnormalities of cerebral perfusion in multiple sclerosis / W.Rashid, L.M.Parkes, G.T.Ingle, D.T.Chard, A.T.Toosy et al. // J. Neurol. Neurosurg. Psychiatry. – 2004. – V. 75 (9). – P. 1288-1293.
147
139)Rosner, K. Role of LFA- 1/ICAM-1, CLA/E-selectin and VLA- 4/VCAM-1 pathways in recruiting leukocytes to the various regions of the chronic leg ulcer / K.Rosner, C.Ross, T.Karlsmark, G.L.Skovgaard // Acta. Derm. Venereol. – 2001. – V. 81(5). – P. 344-349.
140)Rossano, R. Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants / R.Rossano, M.Larocca, L.Riviello, M.G.Coniglio, J.Vandooren et al. // J. Cell. Mol. Med. – 2014. – V. 18(2). – P. 242-252.
141)Rubanyi, G.M. The role of endothelium in cardiovascular homeostasis and diseases / G.M.Rubanyi // J. Cardiovasc. Pharmacol. – 1993. – V. 22(Suppl. 4). – P. S1-S4.
142)Sheremata, W.A. Evidence of platelet activation in multiple sclerosis / W.A.Sheremata, W.Jy, L.L.Horstman, Y.S.Ahn, J.S.Alexander et al. // J. Neuroinflammation. – 2008. – V. 5. – P. 27.
143)Shoenfeld, Y. Accelerated atherosclerosis in autoimmune rheumatic diseases / Y.Shoenfeld, R.Gerli, A.Doria, E.Matsuura, M.M.Cerinic et al. // Circulation. – 2005. – V. 112(21). – P. 3337–3347.
144)Simionescu, M. Segmental differentiations of cell junctions in the vascular endothelium. The microvasculature / M.Simionescu, N.Simionescu, G.E.Palade // J. Cell. Biol. – 1975. – V. 67(3). – P. 863–885.
145)Simionescu, M. Segmental differentiations of cell junctions in the vascular endothelium. Arteries and veins / M.Simionescu, N.Simionescu, G.E.Palade // J. Cell. Biol. – 1976. – V. 68(3). – P. 705–723.
146)Simka, M. Blood brain barrier compromise with endothelial inflammation may lead to autoimmune loss of myelin during multiple sclerosis / M.Simka // Curr. Neurovasc. Res. – 2009. – V. 6(2). – P. 132-139.
148
147) Soilu-Hänninen, M. High sensitivity measurement of CRP and disease progression in multiple sclerosis / M.Soilu-Hänninen, J.O.Koskinen, M.Laaksonen, A.Hänninen, E.M.Lilius et al. // Neurology. – 2005. – V. 65(1).
– P. 153-155.
148)St Croix, B. Genes expressed in human tumor endothelium / B.St Croix, C.Rago, V.Velculescu, G.Traverso, K.E.Romans et al. // Science. – 2000. – V. 289(5482). – P. 1197–1202.
149)Stanimirovic, D.B. Pathophysiology of the neurovascular unit: disease cause or consequence? / D.B.Stanimirovic, A.Friedman // J. Cereb. Blood. Flow. Metab. – 2012. – V. 32(7). – P. 1207–1221.
150)Sundström, P. Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study / P.Sundström, A.Wåhlin, K.Ambarki, R.Birgander,
A.Eklund et al. // Ann. Neurol. – 2010. – V. 68(2). – P. 255–259.
151)Szklarczyk, A. Matrix Metalloproteinases, Synaptic Injury, and Multiple Sclerosis / A.Szklarczyk, K.Conant // Front. Psychiatry. – 2010. – V. 1. – P. 130.
152)Takase, S. Venous hypertension, inflammation and valve remodeling / S.Takase, L.Pascarella, L.Lerond, J.J.Bergan, G.W.Schmid-Schönbein // Eur. J. Vasc. Endovasc. Surg. – 2004. – V. – 28(5). – P. 484-493.
153)Trentini, A. TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis / A.Trentini, M.C.Manfrinato, M.Castellazzi, C.Tamborino, G.Roversi et al. // Mult. Scler. – 2015. – pii: 1352458514560925.
154)Tsukada, N. Soluble E-selectin in the serum and cerebrospinal fluid of patients with multiple sclerosis and human T-lymphotropic virus type 1-
149
associated myelopathy / N.Tsukada, K.Miyagi, M.Matsuda, N.Yanagisawa //
Neurology. – 1995. – V. 45(10). – P. 1914-1918.
155)Van Leuven, S.I. Systemic inflammation as a risk factor for atherothrombosis / S.I.Van Leuven, R.Franssen, J.J.Kastelein, M.Levi, E.S.Stroes et al. // Rheumatology. – 2008. – V. 47(1). – P. 3–7.
156)Vanhoutte, Ed.P.M. Endothelium - Derived Hyperpolarizations / Ed.P.M.Vanhoutte. – Harwood Academic publishers, 1999. – 436 р.
157)Vanhoutte, P.M. Endothelial dysfunction and atherosclerosis / P.M.Vanhoutte // Eur. Heart. J. – 1997. – V. 18(Suppl. E). – P. E19-29.
158)Vaporciyan, A.A. Involvement of platelet endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo / A.A.Vaporciyan, H.M.DeLisser, H.Yan, I.I.Mendiguren, S.R.Thom et al. // Science. – 1993. – V. 262(5139). – P. 1580-1582.
159)Varga, A.W. White matter hemodynamic abnormalities precede subcortical gray matter changes in multiple sclerosis / A.W.Varga, G.Johnson, J.S.Babb, J.Herbert, R.I.Grossman et al. // J. Neurol. Sci. – 2009. – V. 282(1-2)
– P. 28–33.
160) Verslegers, M. Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system / M.Verslegers, K.Lemmens, I.Van Hove, L.Moons // Prog. Neurobiol. – 2013.
– V. 105. – P. 60-78.
161) Virgintino, D. Expression of P-glycoprotein in human cerebral cortex microvessels / D.Virgintino, D.Robertson, M.Errede, V.Benagiano, F.Girolamo et al. // J. Histochem. Cytochem. – 2002. – V. 50(12). – P. 1671– 1676.
150
162)Wakefied, A.J. Immunohistochemical study of vascular injury in acute multiple sclerosis / A.J.Wakefied, L.J.More, J.Difford, J.E. McLaughlin // J. Clin. Pathol. – 1994. – V. 47(2). – P. 129-133.
163)Walters, C.E. Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis / C.E.Walters, G.Pryce, D.J.Hankey, S.M.Sebti, A.D.Hamilton et al. // J. Immunol. – 2002. – V. 168(8). – P. 4087-4094.
164)Washington, R. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis / R.Washington, J.Burton, R.F.Todd, W.Newman, L.Dragovic et al. // Ann. Neurol. – 1994. – V. 35(1). – P. 89—97.
165)Wattjes, M.P. No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study / M.P.Wattjes, B.W.van Oosten, W.L.de Graaf, A.Seewann et al. // J. Neurol. Neurosurg. Psychiatry. – 2011. – V. 82(4). – P. 429–435.
166)Waubant, E. Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis / E.Waubant // Dis. Markers. – 2006. – V. 22(4). – P. 235–
244.
167)Waubant, E. IFN beta lowers MMP-9/TIMP-1 ratio which predicts new enhancing lesions in patients with SPMS / E.Waubant, D.Goodkin, A.Bostrom, P.Bacchetti, J.Hietpas et al. // Neurology. – 2003. – V. 60(1). – P. 52–57.
168)Waubant, E. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis / E.Waubant, D.Goodkin, L.Gee, P.Bacchetti, R.Sloan et al. // Neurology. – 1999. – V. 53(7). – P. 1397–1401.
169)Weksler, B.B. Blood-brain barrier-specific properties of a human adult
brain endothelial cell line / B.B.Weksler, E.A.Subileau, N.Perrière,